Added to YB: 2016-09-15
Pitch date: 2016-09-15
HZNP:US [bullish]
Horizon Therapeutics Public Limited Company
+691.7%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases.
Market Cap
$26.6B
Pitch Price
$14.69
Price Target
N/A
Dividend
N/A
EV/EBITDA
39.41
P/E
61.85
EV/Sales
7.37
Sector
Biotechnology
Category
N/A
Show full summary:
Horizon Therapeutics Public Limited Company HZNP:US
A summary for this pitch has not been created yet.
Read full article (0 min)